DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence
En podcast av DrugPatentWatch
100 Avsnitt
-
Key Factors for Choosing the Right CDMO
Publicerades: 2023-08-28 -
Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry
Publicerades: 2023-08-21 -
Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review
Publicerades: 2023-08-15 -
Drug Patent Reports now available on Amazon
Publicerades: 2023-08-14 -
Artificial Intelligence and Machine Learning in Drug Discovery and Development
Publicerades: 2023-08-10 -
Prevalence and timing of authorized generics in the US market
Publicerades: 2023-08-08 -
Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends
Publicerades: 2023-08-07 -
The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation
Publicerades: 2023-08-05 -
Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study
Publicerades: 2023-08-02 -
Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations
Publicerades: 2023-07-28 -
DrugPatentWatch reveals NIH funding for patents
Publicerades: 2023-07-27 -
Filing Strategies for Maximizing Pharma Patents
Publicerades: 2023-07-25 -
DrugChatter Featured Questions
Publicerades: 2023-06-08 -
DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights
Publicerades: 2023-05-22 -
NPR and DrugPatentWatch – Can drug injector pens be swapped?
Publicerades: 2023-05-16 -
Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges
Publicerades: 2023-04-19 -
Social Return on Investment
Publicerades: 2022-09-06 -
CDCDB: A large and continuously updated drug combination database
Publicerades: 2022-06-07 -
DrugPatentWatch named “Best of the Web” by Genetic Engineering News
Publicerades: 2022-05-02 -
The value of method of use patent claims in protecting your therapeutic assets
Publicerades: 2022-04-05
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
